Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Methylphenidate for Apathy in Alzheimer's Dementia: A Controlled Study
Authors not listed
VA Office of Research and Development · 2007
Abstract
The purpose of the study is to determine the efficacy of methylphenidate over placebo in treating apathy in patients with Alzheimer's dementia. Apathy is one of the earliest and most profound disturbances that occur in Alzheimer's dementia (AD).
Hypotheses: 1. Methylphenidate (MPH) will improve apathy significantly more than placebo in AD.
2\. Successful treatment of apathy will improve Instrumental Activities of Daily Living (IADLs), and caregiver burden.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-11-08 MST
Cite this
APA
Anonymous. (2007). Methylphenidate for Apathy in Alzheimer's Dementia: A Controlled Study. <em>VA Office of Research and Development</em>. https://clinicaltrials.gov/study/NCT00495820
Vancouver
Anonymous. Methylphenidate for Apathy in Alzheimer's Dementia: A Controlled Study. VA Office of Research and Development. 2007.
BibTeX
@misc{anon2007Methyl,
title = {Methylphenidate for Apathy in Alzheimer's Dementia: A Controlled Study},
author = {Anonymous},
journal = {VA Office of Research and Development},
year = {2007},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Ipsen 2002
Open access · US-GOV
Efficacy and Tolerance of EGb 761® 120mg Two Times a Day on Dementia of Alzheimer Type's Onset in Patients Suffering From Memory Complaints. A Randomised, Double-blind, Multicentre, Parallel Groups, Placebo Controlled Phase IIIb/IV Study in Elderly Over 70
Otsuka Pharmaceutical Development & Commercialization, Inc. 2000
Open access · US-GOV
A Multicenter, Randomized, Double-Blind, Placebo Controlled Flexible Dose Study of Aripiprazole in the Treatment of Patients With Psychosis Associated With Dementia of Alzheimer's Type
University of Zurich 2011
Open access · US-GOV
Cognitive-Behavioral Treatment for Patients With Mild Alzheimer's Dementia: A Randomized Controlled Trial
Technische Universität Dresden 2011
Open access · US-GOV
An Easily Accessible Physical Activity Training Program for Patients With Alzheimer's Dementia: Effect on Clinical and Neurobiological Parameters (MOTODEM)
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 2001
Open access · US-GOV
Placebo-Controlled Evaluation of Galantamine in the Treatment of Alzheimer's Disease: Safety and Efficacy of a Controlled-Release Formulation
pico-tesla Magnetic Therapies, LLC 2010
Open access · US-GOV